Lupp A, Lucas N, Lindström-Seppa P, Koponen K, Hänninen O, Danz M, Klinger W
Institute of Pharmacology and Toxicology, Friedrich Schiller University Jena, Germany.
Exp Toxicol Pathol. 1998 Jun;50(3):173-83. doi: 10.1016/s0940-2993(98)80079-1.
In the present study, the effect of beta-naphthoflavone (BNF), phenobarbital (PB) and dexamethasone (DEX) on the expression of three cytochrome P450 (P450) isoforms, 1A1, 2B1 and 3A2, and on glycogen storage was investigated in intrasplenic liver cell explants in comparison to adult liver. Fetal liver tissue suspensions were transplanted into the spleens of adult male syngenic Fisher inbred rats. Four months after surgery, transplant recipients and age matched controls were orally treated with BNF (1 x 50 mg/kg body weight (b.wt.)), PB (1 x 50 mg/kg b.wt.), DEX (for 3 days 4 mg/kg b.wt. per day), or the respective solvents (dimethylsulfoxide or 0.9% NaCl). The animals were sacrificed 24 (BNF, DEX) or 48 (PB) hours after the last treatment. The livers of both solvent treated transplant recipients and control rats displayed only in few liver lobules a slight P450 1A1, but in all lobules a strong P450 2B1 and 3A2 expression, which was all mainly located in the hepatocytes around the central veins (zone III, according to Rappaport). After BNF administration a P450 1A1 expression was induced in the hepatocytes of the peripheral regions of the liver lobules (zone I, according to Rappaport), whereas the staining of the hepatocytes around the central veins disappeared. Also the staining for P450 2B1 in the hepatocytes of zone III became slightly more pronounced. Following PB treatment the P450 1A1 expression in the hepatocytes of the central regions (zone III), as seen in few lobules after solvent treatment only, was reduced, whereas the staining for P450 2B1 and 3A2 was more pronounced in the hepatocytes of the intermedial and central regions of the liver lobules (zone II and III). DEX treatment diminished P450 1A1 and 2B1 expression within the livers of both transplant recipients and control rats. In contrast, the staining for P450 3A2 was enhanced in all regions of the liver lobules. Transplantation of fetal liver tissue suspensions into the spleens did not influence the inducibility of P450 isoforms expression within the respective livers of the animals. Spleens of control rats displayed no P450 isoforms expression without as well as with induction. In the explant containing spleens, however, similar to normal liver, the transplanted hepatocytes displayed nearly no P450 1A1, but a strong P450 2B1 and 3A2 expression. After BNF treatment a staining for P450 1A1 was induced and also the P450 2B1 expression was slightly more pronounced. PB treatment caused an increase in the staining for P450 2B1 and 3A2 and DEX administration for P450 3A2 within the transplanted hepatocytes. Additionally, after DEX treatment some bile ducts of the explants displayed a slight staining for P450 1A1, 2B1 and 3A2. All hepatocytes within the livers of both solvent treated transplant recipients and control rats displayed a slightly PAS-positive cytoplasma and, in most cases, homogeneously distributed, fine-grained, strongly PAS-stained granules indicating glycogen storage. No regional variance in the glycogen content of the hepatocytes was seen within the liver lobules, but there was a marked difference between the individual hepatocytes of the same lobular region in the extent of glycogen accumulation. The hepatocytes within the explants displayed the same type of glycogen storage as did the adult liver cells. BNF treatment did not display any effect on the glycogen accumulation in livers and intrasplenic liver cell explants. After PB administration, only in livers, but not in the transplants, the glycogen content in the hepatocytes around the central veins was slightly reduced. DEX treatment lead to an excessive storage of fat within the hepatocytes of both livers and spleens. Thus, the glycogen was displaced, leading to a "spoke-wheel" like pattern of glycogen storage. Additionally, within the hepatocytes of both livers and liver cell explants a higher amount of glycogen seemed to be stored and the granules appeared to be more coarse-grained. (ABSTRACT
在本研究中,与成年肝脏相比,研究了β-萘黄酮(BNF)、苯巴比妥(PB)和地塞米松(DEX)对脾内肝细胞外植体中三种细胞色素P450(P450)同工型1A1、2B1和3A2表达以及糖原储存的影响。将胎肝组织悬液移植到成年雄性同基因Fisher近交系大鼠的脾脏中。术后4个月,给移植受体和年龄匹配的对照口服BNF(1×50mg/kg体重(b.wt.))、PB(1×50mg/kg b.wt.)、DEX(连续3天,每天4mg/kg b.wt.)或相应溶剂(二甲基亚砜或0.9%NaCl)。在最后一次治疗后24小时(BNF、DEX)或48小时(PB)处死动物。溶剂处理的移植受体和对照大鼠的肝脏仅在少数肝小叶中显示轻微的P450 1A1表达,但在所有小叶中均显示强烈的P450 2B1和3A2表达,且均主要位于中央静脉周围的肝细胞中(根据Rappaport分类为III区)。给予BNF后,肝小叶周边区域(根据Rappaport分类为I区)的肝细胞中诱导出P450 1A1表达,而中央静脉周围肝细胞的染色消失。III区肝细胞中P450 2B1的染色也略有增强。PB处理后,仅在溶剂处理后少数小叶中可见的中央区域(III区)肝细胞中的P450 1A1表达降低,而肝小叶中间和中央区域(II区和III区)肝细胞中P450 2B1和3A2的染色更明显。DEX处理降低了移植受体和对照大鼠肝脏内P450 1A1和2B1的表达。相反,肝小叶所有区域中P450 3A2的染色增强。将胎肝组织悬液移植到脾脏中不影响动物相应肝脏内P450同工型表达的诱导性。对照大鼠的脾脏在未诱导和诱导后均未显示P450同工型表达。然而,在含有外植体的脾脏中,与正常肝脏相似,移植的肝细胞几乎不显示P450 1A1,但显示强烈的P450 2B1和3A2表达。BNF处理后诱导出P450 1A1染色,P450 2B1表达也略有增强。PB处理导致移植肝细胞内P450 2B1和3A2染色增加,DEX处理导致P450 3A2染色增加。此外,DEX处理后,外植体的一些胆管显示出轻微的P450 1A1、2B1和3A2染色。溶剂处理的移植受体和对照大鼠肝脏内的所有肝细胞均显示细胞质轻微PAS阳性,且在大多数情况下,有均匀分布的、细颗粒状、强烈PAS染色的颗粒,表明存在糖原储存。肝小叶内肝细胞的糖原含量未见区域差异,但同一小叶区域内单个肝细胞的糖原积累程度存在明显差异。外植体内的肝细胞与成年肝细胞显示相同类型的糖原储存。BNF处理对肝脏和脾内肝细胞外植体中的糖原积累无任何影响。给予PB后,仅在肝脏中,而非移植体中,中央静脉周围肝细胞中的糖原含量略有降低。DEX处理导致肝脏和脾脏的肝细胞内脂肪过度储存。因此,糖原被取代,导致糖原储存呈“辐条轮”样模式。此外,肝脏和肝细胞外植体的肝细胞内似乎储存了更多的糖原,且颗粒似乎更粗大。(摘要)